No effect of nebulised adrenaline on clinically important outcomes in viral bronchiolitis

Wood D
October 2003
Thorax;Oct2003, Vol. 58 Issue 10, p871
Academic Journal
No abstract available.


Related Articles

  • Repeated dosing of nebulised 5% saline improves respiratory scores in inpatients with mild to moderate bronchiolitis at 48 h. Ralston, Shawn // Evidence Based Medicine;Jun2011, Vol. 16 Issue 3, p82 

    The article presents a study which examined the effectiveness of nebulised hypertonic saline as a treatment for acute viral bronchiolitis in children. In the study, children aged up to 18 months primarily diagnosed with acute bronchiolitis in Qatar were subjected to a randomised trial. It...

  • Data on treating bronchiolitis is severely limited. King, V. J.; Viswanathan, M.; Bordley, W. C. // BMJ: British Medical Journal (International Edition);6/5/2004, Vol. 328 Issue 7452, p1326 

    Presents an evaluation of data for treating bronchiolitis. Report on the effectiveness of the various treatments for bronchiolitis; Lack of thorough clinical trials of treatments for bronchiolitis; Claim that the treatments available may be effective, but unproved because of a lack of studies...

  • Towards evidence based medicine for paediatricians. Philips, Bob // Archives of Disease in Childhood;Dec2002, Vol. 87 Issue 6, p548 

    Discusses whether nebulized adrenaline, or epinephrine, reduces admission rate in bronchiolitis. Key research findings that demonstrate a reduction in hospital admission with adrenaline; Importance of the alpha-adrenergic properties of adrenaline in bronchiolitis; Implications on acute pediatrics.

  • Question 2 Does combined oral dexamethasone and epinephrine inhalation help infants with bronchiolitis to recover faster? QM van Dellen // Archives of Disease in Childhood;Jun2011, Vol. 96 Issue 6, p606 

    The article focuses on the use of the combination of oral dexamethasone and epinephrine inhalation to help infants with bronchiolitis recover faster. It states that viral bronchiolitis is the most common lower respiratory tract infection among infants in the U.S., and that the effectiveness of...

  • Current therapy for bronchiolitis. Nagakumar, Prasad; Doull, Iolo // Archives of Disease in Childhood;Sep2012, Vol. 97 Issue 9, p827 

    Bronchiolitis is a common, self-limiting, seasonal viral respiratory tract infection in infancy accounting for the majority of hospital admissions in this age group. Supportive care is the mainstay of treatment, concentrating on fluid replacement, gentle suctioning of nasal secretions, prone...

  • SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Everard, Mark L.; Hind, Daniel; Ugonna, Kelechi; Freeman, Jennifer; Bradburn, Mike; Cooper, Cindy L.; Cross, Elizabeth; Maguire, Chin; Cantrill, Hannah; Alexander, John; McNamara, Paul S. // Thorax;Dec2014, Vol. 69 Issue 12, p1105 

    Aim Acute bronchiolitis is the commonest cause for hospitalisation in infancy. Supportive care remains the cornerstone of current management and no other therapy has been shown to influence the course of the disease. It has been suggested that adding nebulised hypertonic saline to usual care may...

  • Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study. Hogan, Alice; Bonney, Mary-Ann; Brien, Jo-anne; Karamy, Rita; Aslani, Parisa // International Journal of Clinical Pharmacy;Feb2015, Vol. 37 Issue 1, p86 

    Background Nebulised medicines contribute to the high treatment burden experienced by patients with cystic fibrosis (CF). Objectives This study explored experiences of adult patients with CF when using nebulised medicines, factors impacting on their adherence to nebulised therapy and strategies...

  • EDUCATION PRACTICE. Bronchiolitis in children: summary of NICE guidance. Ricci, Valentina; Delgado Nunes, Vanessa; Murphy, M. Stephen; Cunningham, Steve // BMJ: British Medical Journal;6/6/2015, Vol. 350 Issue 8011, ph2305 

    The article discusses how to diagnose and manage infants and children with bronchiolitis based on recommendations from the National Institute for Health and Care Excellence. Topics include when to refer, to admit, and to discharge children with bronchiolitis, drugs to avoid when treating...

  • Short term effects of adrenaline in bronchiolitis: a randomised controlled trial. Abul-Ainine, A.; Luyt, D. // Archives of Disease in Childhood;Apr2002, Vol. 86 Issue 4, p276 

    Background: Airway narrowing in acute bronchiolitis does not respond to inhaled bronchodilators but does to adrenaline when compared to bronchodilators. Influences of supportive care were not considered in previous treatment studies. Methods: Short term effects of nebulised adrenaline and saline...

  • Virus Type and Genomic Load in Acute Bronchiolitis: Severity and Treatment Response With Inhaled Adrenaline. Skjerven, Håvard O.; Megremis, Spyridon; Papadopoulos, Nikolaos G.; Mowinckel, Petter; Carlsen, Kai-Håkon; Lødrup Carlsen, Karin C.; ORAACLE Study Group // Journal of Infectious Diseases;3/15/2016, Vol. 213 Issue 6, p915 

    Background: Acute bronchiolitis frequently causes infant hospitalization. Studies on different viruses or viral genomic load and disease severity or treatment effect have had conflicting results. We aimed to investigate whether the presence or concentration of individual or multiple...


Read the Article


Sign out of this library

Other Topics